Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
20 Results for "
HPV E7
" in MedChemExpress (MCE) Product Catalog:
Products (20)
20 Results for "HPV E7" in MCE Product Catalog:
4
4 Cited Publications
Synonyms: VERU-111; ABI-231
Target:
Research Areas:
VERU-111 (ABI-231) is a potent and orally active α and β tubulin inhibitor, which displays strong antiproliferative activity, with an average IC50 of 5.2 nM against panels of melanoma and prostate cancer cell lines. VERU-111 (ABI-231) suppresses tumor growth and metastatic phenotypes of cervical cancer cells via targeting HPV E6 and E7, and has potential for the treatment of prostate cancer .
Cat. No.: HY-P1907
CAS No.: 151812-18-9
Cat. No.: HY-P1778
CAS No.: 160212-93-1
Cat. No.: HY-146033
CAS No.: 331851-78-6
HPV18-IN-1 (Compound H1) is a potent inhibitor of HPV18. HPV18-IN-1 prevents cervical cancer cells from premature cell procession and abnormal proliferation. HPV18-IN-1 supresses E7-Rb-E2F cellular pathway and DNA methylation. HPV18-IN-1 has the potential for the research of cancer diseases .
Cat. No.: HY-P1881
CAS No.: 160040-04-0
Cat. No.: HY-P702859
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Protein E7; E7
Species:
Virus
Source:
E. coli
Cat. No.: HY-189230
CAS No.: 3108114-67-3
Target:
Research Areas:
NEP48 is a small-molecule antagonist targeting the ZER1 (E3 ubiquitin ligase)-E7 oncogenic axis. NEP48 binds to the MHGD/N-degron binding pocket within the ARM repeat domain of ZER1, competitively blocking E7-ZER1 binding and ZER1-mediated substrate degradation. NEP48 disrupts the ZER1-E7 interaction, leading to Rb stabilization and silencing of E2F-driven transcriptional programs. NEP48 inhibits the proliferation of HPV-positive cancer cells and can be used for research on HPV-positive cervical cancer .
Cat. No.: HY-N20712
CAS No.: 59632-76-7
Cat. No.: HY-P700917
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: HPV16; E7; MHC
Species:
Human
Source:
HEK293
Cat. No.: HY-P700918
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: HPV16; E7; MHC
Species:
Human
Source:
HEK293
Cat. No.: HY-P700916
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: HPV16; E7; MHC
Species:
Human
Source:
HEK293
Cat. No.: HY-P705369
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: HLA-B*0702; B2M; HPV16 E7 (KPTLKEYVL)
Species:
Human
Source:
HEK293
Cat. No.: HY-P701258
Synonyms: HLA-A*0201; B2M; HPV16-E7 (YMLDLQPET)
Species:
Human
Source:
HEK293
Cat. No.: HY-P705356
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: HLA-A*1101; B2M; EGF R (KITDFGRAK)
Species:
Human
Source:
HEK293
Cat. No.: HY-P705030
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: HLA-A*0201; B2M; HPV16-E7 (YMLDLQPET)
Species:
Human
Source:
HEK293
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
